U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
nesvacumab [INN]
Preferred Name English
NESVACUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN MONOCLONAL REGN910 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN910 LIGHT CHAIN, DIMER
Common Name English
REGN910
Code English
NESVACUMAB [USAN]
Common Name English
REGN-910
Code English
Nesvacumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1742
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL2108678
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
WIKIPEDIA
Nesvacumab
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
NCI_THESAURUS
C95712
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109297
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
FDA UNII
WX8293WGLC
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
USAN
ZZ-34
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
SMS_ID
100000174999
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
INN
9688
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
DRUG BANK
DB15330
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
CAS
1296818-77-3
Created by admin on Mon Mar 31 21:35:11 GMT 2025 , Edited by admin on Mon Mar 31 21:35:11 GMT 2025
PRIMARY
ACTIVE MOIETY
NESVACUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966